Silco Pharmaceuticals Limited (DSE:SILCOPHL)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
14.10
-0.10 (-0.70%)
At close: May 12, 2025
-28.06%
Market Cap 1.46B
Revenue (ttm) 428.63M
Net Income (ttm) 46.56M
Shares Out 103.81M
EPS (ttm) 0.45
PE Ratio 31.23
Forward PE n/a
Dividend 0.10 (0.70%)
Ex-Dividend Date Dec 9, 2024
Volume 211,290
Average Volume 186,257
Open 14.20
Previous Close 14.20
Day's Range 13.90 - 14.50
52-Week Range 12.60 - 23.90
Beta 0.24
RSI 40.55
Earnings Date Apr 29, 2025

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 313
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SILCOPHL
Full Company Profile

Financial Performance

In 2024, Silco Pharmaceuticals's revenue was 410.10 million, a decrease of -11.75% compared to the previous year's 464.70 million. Earnings were 45.88 million, a decrease of -33.72%.

Financial Statements

News

There is no news available yet.